Artificial Intelligence

As COO/CFO Ashim Gupta prepares for a key investor conference, UiPath aims to prove its 'agentic automation' strategy can deliver sustained growth.

With star hires and proprietary data analytics, Abacus Global Management is making an ambitious play for the booming asset-based finance sector.

With its first drug approved and a deep pipeline, all eyes are on Nuvation Bio's CEO David Hung at the upcoming J.P. Morgan Healthcare Conference.

A new $65 million facility for a top U.S. intelligence lab cements Maryland's role as a national security research powerhouse. Here's what it means.

LifeVantage heads to the ICR Conference to woo investors. Can its cellular health science overcome market headwinds and a volatile direct selling landscape?

In a major strategic shift, cybersecurity leader Coalfire appoints Google Cloud veteran Brad Little as CEO to drive growth in AI and cloud modernization.

Finance software leader OneStream agrees to a $6.4B private equity buyout by Hg, aiming to fast-track its AI strategy less than two years after its IPO.

An exclusive NYC roundtable will give real estate leaders rare access to reporters from WSJ and AP on how media narratives will shape the market.

A landmark trial reveals a new drug combination from BeOne Medicines extends life significantly in advanced stomach cancer, poised to become the new standard.

Dutch tech firm Aquablu unveils its BOLD system at CES, using AI and wearable data to deliver personalized, sustainable hydration to US offices and gyms.

ASUS's new ExpertCenter Pro ET900N G3, powered by NVIDIA's Grace Blackwell Ultra, brings petaflop-scale AI power out of the data center and onto the desktop.

As digital cockpits grow more complex, Teledyne LeCroy's new testing tools for the DisplayPort AE standard are set to ensure unprecedented safety and security.

The insatiable energy demands of AI are creating a crisis and an opportunity, forcing developers to build power plants alongside warehouses.

UBC's strategic buyout of AI-specialist Evidinno signals a major shift in evidence generation, promising faster, smarter data solutions for biopharma.

With new funding, the foundation aims to empower nurses on the front lines, fueling solutions for healthcare's most vulnerable populations.

By blending AI innovation with a 'whole person' wellness philosophy, MERGE sets a new standard for employee experience and industry leadership.

Siemens' new Digital Twin Composer, powered by NVIDIA AI, is helping PepsiCo achieve massive efficiency gains, proving the industrial metaverse is here.

Facing declining revenue but armed with a strong AI vision, Unisys CEO Mike Thomson prepares to address investors at the critical Needham Growth Conference.

With its lead asset TEC-001 targeting tough liver cancers, Teclison's presence at the ASCO GI Symposium puts its innovative approach in the spotlight.

With a new CEO who has three FDA-approved drugs to his name, Catalio-backed Rhapsogen is poised to redefine autoimmune disease treatment. Here's why.